Skip to main content
Equibles
SRTS logo

SRTS · Sensus Healthcare, Inc.

Track SRTS — free

Use SRTS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SRTS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.86 -0.30 (-9.49%) At close · Aug 14
Market Cap
$47.08M
Shares
16.46M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.86 Open$2.80 Day$2.80–2.98 52W close$2.69–5.30 Avg vol 30d22K Short int206K · 1.3% float · 10.2d Short vol38% Last earningsAug 13, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 14

Up next

Next earnings call
Nov 16, 2026 Est · unconfirmed · in 13 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 14, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −25%
      below
      Price vs 50-day avg −3%
      below
      RSI (14) 41
      neutral
      MACD trend Positive
      52-week position 7%
      near low
      Momentum
      relative strength
      Very Weak
      1-month return −5%
      trailing
      6-month return −25%
      trailing
      YTD return −28%
      this year
      Relative strength −39%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $3 › 200d $4 — 200d above 50d
      Institutional flow Distributing
      -9% holders QoQ · +4 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      1.25% of float · ▲ +1.9% MoM · 10.2 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Multi-yr low
      40 holders — near 3-yr low, contrarian setup
      Squeeze score 62
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −34%
      Y/Y
      Gross margin 43%
      contracting
      EPS growth −215%
      Y/Y
      Free cash flow $332.0K
      Balance sheet $21.8M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 64%
      annualized · 1-yr
      Max drawdown −49%
      past year
      ATR 5.1%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Prior guidance period ended · from the Earnings Call filed Mar 31, 2025
      G&A expenses · for the rest of the year $1.8M
      Sales and marketing expenses · going forward $1.3M
      R&D expenses · for the balance of the year $1.5M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      2 · 3 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −25% Bearish
      Price vs 50-day avg
      −3% Neutral
      RSI (14)
      41 Neutral
      MACD trend
      Positive Bullish
      52-week position
      7% Bearish
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $3 › 200d $4 — 200d above 50d
      Institutional flow Distributing
      -9% holders QoQ · +4 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      1.25% of float · ▲ +1.9% MoM · 10.2 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Multi-yr low
      40 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      Range low $3 Now $3 · 7% Range high $5
      vs 200-day avg -25% vs 50-day avg -3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Active sites (Fair Deal Agreement program) 18 as of March 31, 2026 —
      Sites pending activation (Fair Deal Agreement program) 9 as of March 31, 2026 —
      FDA patients treated 922 full year 2025 —
      FDA treatments delivered 11,411 full year 2025 —
      SRT systems shipped in the U.S. 56 full year 2025 —
      SRT systems shipped internationally 14 full year 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      SRTS
      Sensus Healthcare, Inc.
      this stock
      		$47.08M -28.1% -34.3% — 1.3%
      ABT
      Abbott Laboratories
      		 $193.78B -11.2% +5.7% 31.2 1.3%
      SYK
      Stryker Corp
      		 $130.11B -3.5% +11.2% 35.2 2.2%
      MDT
      Medtronic plc
      		 $116.83B -5.0% +8.4% 24.5 1.4%
      BSX
      Boston Scientific Corp
      		 $75.11B -45.6% +12.5% 21.0 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      40
      % held
      22.7%
      Net QoQ
      -271.9K sh
      Top holder
      Pacific Ridge Capital Par…
      Held Float
      View
      Held by Funds
      Fund positions
      31
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      205.9K
      Days to cover
      10.2d
      Change
      +3.8K sh
      View
      Short Volume
      Short vol %
      38%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      3.1K
      Value
      $9.4K
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      44.6%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $27.5M
      Net income (FY)
      $-7.7M
      EPS diluted
      $-0.47
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 14, 2026
      This year
      12
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 13, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      SRTS -6.8% -5.3% -25.1% -1.7% -28.1%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -7.2% -9.8% -38.9% -5.6% -42.0%
      Key facts CIK 1494891 CUSIP 81728J109 13F (30d) 38 filings 38 filers Visit website

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)